Adverse Events in the OlympiA Trial

  • The most common advérese events (AE) observed in the olaparib arm during the OlympiA trial were:
    • Nausea, fatigue, anemia, and vomiting:
      • Most of which were of grade 1 or 2
  • At the updated analysis, no new safety signals were detected (including no new cases of acute myeloid leukemia or myelodysplastic syndrome)
#Arrangoiz #BreastSurgeon #CancerSurgeon #SurgicalOncologist #MountSinaiMedicalCenter #MSCM #Miami #Mexico #BreastCancer

Leave a comment